1. Home
  2. RNST vs AMRX Comparison

RNST vs AMRX Comparison

Compare RNST & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RNST

Renasant Corporation

HOLD

Current Price

$43.96

Market Cap

4.0B

Sector

Finance

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$18.70

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNST
AMRX
Founded
1904
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
5.8B
IPO Year
1997
2018

Fundamental Metrics

Financial Performance
Metric
RNST
AMRX
Price
$43.96
$18.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$43.00
$15.60
AVG Volume (30 Days)
666.3K
1.8M
Earning Date
04-28-2026
05-01-2026
Dividend Yield
2.31%
N/A
EPS Growth
N/A
157.89
EPS
0.94
0.19
Revenue
N/A
N/A
Revenue This Year
$31.72
$4.48
Revenue Next Year
$4.67
$7.13
P/E Ratio
$46.07
$95.21
Revenue Growth
N/A
N/A
52 Week Low
$33.04
$7.67
52 Week High
$44.50
$18.39

Technical Indicators

Market Signals
Indicator
RNST
AMRX
Relative Strength Index (RSI) 59.76 70.49
Support Level $41.04 $12.46
Resistance Level $44.00 N/A
Average True Range (ATR) 1.00 0.56
MACD -0.00 -0.01
Stochastic Oscillator 87.92 96.30

Price Performance

Historical Comparison
RNST
AMRX

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has two reportable segments: Community banks and Wealth management. With its Community Banks segment, the company provides a range of financial services to individuals and small businesses. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: